文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新发 IV 期三阴性乳腺癌中特定部位转移和手术的预后价值:基于人群的分析。

Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.

机构信息

Department of Oncology, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University, Meizhou, Guangdong, China (mainland).

出版信息

Med Sci Monit. 2020 Feb 11;26:e920432. doi: 10.12659/MSM.920432.


DOI:10.12659/MSM.920432
PMID:32043484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7034402/
Abstract

BACKGROUND This retrospective study aimed to evaluate the prognostic roles of distant metastatic patterns in de novo metastatic triple-negative breast cancer to explore the roles of surgery on the primary tumor and to characterize the prognostic factors of organ-specific metastasis. MATERIAL AND METHODS Data were obtained from the Surveillance, Epidemiology, and End Results program. Kaplan-Meier analyses and log-rank tests were employed to compare survival outcomes among variables. The Cox proportional hazards model was used to assess risk factors for survival. The key endpoints were overall survival and breast cancer-specific survival. RESULTS A total of 1888 patients were eligible. Distant metastatic site displayed a significant prognostic impact on survival. Using liver metastasis as the reference, overall survival was higher for bone (hazard ratio [HR] 0.770, 95% confidence interval [CI] 0.634-0.935, P=0.008) and lung (HR 0.747, 95% CI 0.612-0.911, P=0.004) metastases. Using patients with brain metastasis as the reference, patients with bone (HR 0.516, 95% CI 0.392-0.680, P<0.001), lung (HR 0.500, 95% CI 0.379-0.661, P<0.001) or liver (HR 0.670, 95% CI 0.496-0.905, P=0.009) metastases exhibited better overall survival. Single-site metastatic patients who received surgery for the primary tumor had more favorable overall survival (P<0.001) and breast cancer-specific survival (P<0.001) than those who did not. Additionally, age, insurance status, chemotherapy, and surgery affected overall survival for patients with isolated bone metastasis; chemotherapy, and surgery affected overall survival for patients with isolated lung metastasis; and insurance status, chemotherapy, and surgery affected overall survival for patients with isolated liver metastasis. CONCLUSIONS Our study verified the specific prognostic significance of distant metastatic site for metastatic triple-negative breast cancer at diagnosis. Surgery on the primary tumor significantly improved survival for patients with single distant metastasis. The identified prognostic factors contributed to evaluating the prognoses for distant metastatic triple-negative breast cancer patients.

摘要

背景:本回顾性研究旨在评估初诊转移性三阴性乳腺癌的远处转移模式的预后作用,以探讨手术对原发性肿瘤的作用,并描述器官特异性转移的预后因素。

材料与方法:数据来自监测、流行病学和最终结果(Surveillance, Epidemiology, and End Results,SEER)计划。采用 Kaplan-Meier 分析和对数秩检验比较变量之间的生存结果。Cox 比例风险模型用于评估生存的危险因素。主要终点是总生存和乳腺癌特异性生存。

结果:共纳入 1888 例患者。远处转移部位对生存具有显著的预后影响。以肝转移为参照,骨转移(风险比[HR]0.770,95%置信区间[CI]0.634-0.935,P=0.008)和肺转移(HR 0.747,95%CI 0.612-0.911,P=0.004)的总生存更高。以脑转移患者为参照,骨转移(HR 0.516,95%CI 0.392-0.680,P<0.001)、肺转移(HR 0.500,95%CI 0.379-0.661,P<0.001)或肝转移(HR 0.670,95%CI 0.496-0.905,P=0.009)的患者总生存更好。接受原发性肿瘤手术的单一部位转移患者的总生存(P<0.001)和乳腺癌特异性生存(P<0.001)优于未接受手术的患者。此外,年龄、保险状况、化疗和手术影响孤立性骨转移患者的总生存;化疗和手术影响孤立性肺转移患者的总生存;保险状况、化疗和手术影响孤立性肝转移患者的总生存。

结论:本研究验证了远处转移部位对初诊转移性三阴性乳腺癌的特定预后意义。原发性肿瘤手术显著改善了单一远处转移患者的生存。确定的预后因素有助于评估远处转移性三阴性乳腺癌患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/63284131b4c5/medscimonit-26-e920432-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/f48a2ea633e7/medscimonit-26-e920432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/fba9e21652d0/medscimonit-26-e920432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/6e1132e4a69c/medscimonit-26-e920432-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/e87bc5cc9d5b/medscimonit-26-e920432-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/6b4c00d062c0/medscimonit-26-e920432-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/7f772fd8fdb8/medscimonit-26-e920432-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/2c70de95af1e/medscimonit-26-e920432-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/63284131b4c5/medscimonit-26-e920432-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/f48a2ea633e7/medscimonit-26-e920432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/fba9e21652d0/medscimonit-26-e920432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/6e1132e4a69c/medscimonit-26-e920432-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/e87bc5cc9d5b/medscimonit-26-e920432-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/6b4c00d062c0/medscimonit-26-e920432-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/7f772fd8fdb8/medscimonit-26-e920432-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/2c70de95af1e/medscimonit-26-e920432-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8c/7034402/63284131b4c5/medscimonit-26-e920432-g008.jpg

相似文献

[1]
Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.

Med Sci Monit. 2020-2-11

[2]
Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.

World J Gastroenterol. 2017-3-14

[3]
Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis.

Cancer Med. 2020-1

[4]
Prognostic value of distant metastatic sites in stage IV endometrial cancer: A SEER database study of 2948 women.

Int J Gynaecol Obstet. 2020-1-7

[5]
Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.

Gynecol Oncol. 2018-7-9

[6]
Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study.

Technol Cancer Res Treat. 2020

[7]
De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.

Clin Exp Metastasis. 2017-12-29

[8]
The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.

PLoS One. 2018-8-13

[9]
The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.

Prostate. 2018-5

[10]
Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.

Eur J Cancer. 2017-3

引用本文的文献

[1]
Patterns and prognostic implications of distant metastasis in breast Cancer based on SEER population data.

Sci Rep. 2025-7-23

[2]
Nomogram for predicting survival in breast cancer with lung metastasis based on SEER data.

Transl Cancer Res. 2025-2-28

[3]
Early death prediction model for breast cancer with synchronous lung metastases: an analysis of the SEER database.

Gland Surg. 2024-10-31

[4]
A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.

Am J Clin Oncol. 2024-2-1

[5]
A visualized model for identifying optimal candidates for aggressive locoregional surgical treatment in patients with bone metastases from breast cancer.

Front Endocrinol (Lausanne). 2023

[6]
Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer.

Transl Cancer Res. 2022-12

[7]
Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer.

Comput Math Methods Med. 2022-8-11

[8]
Development and Validation of Prognostic Nomogram for Elderly Breast Cancer: A Large-Cohort Retrospective Study.

Int J Gen Med. 2022-1-4

[9]
Breast Cancer Subtypes and Mortality of Breast Cancer Patients With Brain Metastasis at Diagnosis: A Population-Based Study.

Inquiry. 2021

[10]
Decreased microRNA-768-3p expression indicates a poor prognosis in patients with breast cancer and promotes breast cancer cell viability, migration and invasion.

Oncol Lett. 2021-8

本文引用的文献

[1]
Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer.

Ann Oncol. 2018-8-1

[2]
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.

BMC Cancer. 2018-4-19

[3]
Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.

Eur J Surg Oncol. 2018-1-9

[4]
Cancer statistics, 2018.

CA Cancer J Clin. 2018-1-4

[5]
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol. 2018-1-3

[6]
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.

CA Cancer J Clin. 2017-1-17

[7]
The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study.

Oncotarget. 2017-4-18

[8]
Survival of de novo stage IV breast cancer patients over three decades.

J Cancer Res Clin Oncol. 2017-3

[9]
Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study.

Clin Exp Metastasis. 2017-1

[10]
Biology and Management of Patients With Triple-Negative Breast Cancer.

Oncologist. 2016-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索